If you are not affiliated with a college or university, and are interested in watching this film, please register as an individual and login to rent this film. Already registered? Login to rent this film.
The recent history of drug patents in India has had a significant impact on world health. For over fifteen years, India has been largely self-sufficient as a manufacturer of generic pharmaceuticals. Poor families benefited from India's historic 1970 Drug Patent Law, which granted patents on the process rather than the product. Low costs means it's also been a major supplier in producing affordable drugs for the rest of the developing world, especially Africa and Asia.
Now, India's $4.5 billion pharmaceutical industry is at a crossroads following a new law introduced there in January 2005. TRIPS (Trade-Related aspects of Intellectual Property Rights) is an agreement drawn up by the World Trade Organization between 1986 and 1994 to ensure intellectual property rights are respected within international trade. The government says that despite the new law, they are committed to supplying drugs at an affordable price. But those actually working in the health system have doubts.
'The visual impact of the gripping documentaries in the Life 5 series make them extremely powerful teaching tools for university, and indeed, other classrooms. In succinct episodes they raise and contextualise some of the most critical issues in the world today. These episodes are produced in an extremely objective manner and allow an audience easily to come to grips with an array of complex problems. They ought to be an indispensable part of the teaching curriculum.' Dr. Jeremy Sarkin, Visiting Professor of International Human Rights, Tufts University
'The importance of these films is that they are intended to raise awareness about global issues in young people, and can be used by anyone for this purpose. The quality of the films is excellent. They are documentaries about the U.N. Millennium Development Goals and include brief interviews with people who are actually involved in MDG programs, from various institutions and from the grassroots to executive level...The objective evidence about the current global crisis of insecurity, poverty, gender inequalities, environmental degradation, and lack of international cooperation is presented in a way that is both realistic and non-inflammatory.
Children are the future. Educational materials such as the Bullfrog Films are very important for the future of both humanity and the human habitat...The Bullfrog Films certainly can and should be shown to children, especially to high school students. But these films are most appropriate for those who prepare the children for responsible citizenship, including global citizenship. They are certainly appropriate for parents who want their children to know about the need for human solidarity and environmental sustainability. And, they are most appropriate for training teachers to plant the seed of global concerns in their students' minds and hearts.' Luis Gutierrez, Editor, Solidarity, Sustainability, and Non-Violence Research Newsletter
Citation
Main credits
Mohan, Reena (film director)
Malde, Smita (editor of moving image work)
Kelly, Brenda (film producer)
Bower, Dick (film producer)
Andoh, Adjoa (narrator)
Other credits
Editor, Smita Malde; executive producer, Brenda Kelly; series producer, Dick Bower.
Anthropology; Asian Studies; Business Practices; Ethics; Globalization; HIV/AIDS; Health; Human Rights; Humanities; India; Millennium Development Goals; Science, Technology, Society; Social Justice; Sociology; United Nations
Keywords
India, India's pharmaceutical industry, drug patents, world health, generic phamaceuticals, generic drugs, drug patent law, developing world, Africa, Asia, TRIPS, WTO, HIV/ AIDS, affordable drugs, intellectual property rights, international trade, health system; "Kill Or Cure?"; Bullfrog Films
Distributor: Bullfrog Films
Length: 26 minutes
Date: 2006
Genre: Expository
Language: English
Grade: 7-12, College, Adult
Color/BW:
Closed Captioning: Available
Existing customers, please log in to view this film.